Valent BioSciences Announces Major Expansion at Its Osage Facility

FOR IMMEDIATE RELEASE

OSAGE, Iowa, June 6, 2022 – Valent BioSciences LLC announced today that it has approved a major expansion of its biorational manufacturing facility in Osage, Iowa, which will meet increasing demand for its biorational products and the introduction of new products requiring more capacity. Construction will begin this summer and will be completed during the second quarter of 2024.

Production-scale fermentation and recovery equipment will be installed with full digital capabilities to produce products that increase crop yields, preserve forests, and protect the public from vector-borne diseases.

A new pilot plant facility with state-of-the-art development equipment will be included in the project. This will be used to accelerate introduction of new products and provide additional capacity and instrumentation to analyze and improve existing fermentation performance.

In addition, laboratory, office, maintenance, and warehouse areas will be expanded as part of the project plan to house additional employees and provide an enhanced workplace environment.

When it was completed in 2014, the Osage plant was the world’s largest purpose-built biorational manufacturing facility. Since then, Valent BioSciences has continued to invest significant resources in expanding its research and manufacturing capabilities at the site and satisfying the company’s tremendous business growth. This expansion will enable the company to maintain state-of-the-art facilities and help meet rising demand for the many biorational products that are made in Osage.

The Osage facility also incorporates the latest sustainable technologies. The expansion will use forward-thinking practices that reduce overall CO2 emissions, energy usage, and wastewater volumes. Recently, Valent BioSciences announced two high-profile environmental initiatives in Mitchell County, Iowa, on land adjacent to the Osage facility.

The first is the restoration of 34 acres of native prairie accessible to the public that will establish a diverse native habitat for birds, butterflies, insects, reptiles, and small wildlife.

The second is a 1.5-megawatt alternating current (AC) solar field. In collaboration with Heartland Power and One Energy this will be constructed on 12 acres of land next to the prairie restoration project, which will provide approximately 8% of the Osage facility’s total annual electricity usage.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:

John Mandel
Valent BioSciences LLC
+1-847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

First Novel Mosquito Adulticide Mode of Action in 50 Years Granted Experimental Use Permit by U.S. EPA

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., April 14, 2022 – The U.S. Environmental Protection Agency recently granted Valent BioSciences LLC an Experimental Use Permit (EUP) to perform further field studies of VBC-60748, a new mosquito space spray targeting pyrethroid-resistant adult mosquitoes.

VBC-60748 is the first-ever mosquito adulticide that contains an active ingredient based on a soil bacterium. That active ingredient is manufactured through fermentation and the product would be the first new U.S. adulticide mode of action approved in 50 years.

Pyrethroid resistance is a worldwide public health threat that limits our ability to control disease-carrying adult mosquitoes. Resistant mosquitoes spread deadly and debilitating diseases such as malaria, West Nile virus, dengue, yellow fever, zika and others.

Disease-vectoring mosquitoes have developed mechanisms that shield them from the insecticidal activity of pyrethroids, one of the most important classes of insecticides for mosquito abatement. Valent BioSciences’ novel adulticide combines three active ingredients and three modes of action to achieve a high level of mortality against these resistant populations across multiple species, as well as against pyrethroid-susceptible mosquitoes.

“We launched this project to bring the global vector control community something very specific,” said Jason Clark, Valent BioSciences’ Global Business Manager. “To make it happen, we would need multiple active ingredients to target multiple sites within the mosquito, and they all would all have to ‘play nice’ in one formulation. We believe that we have succeeded and are now focused on the proper regulatory procedures to confirm so.”

The EUP will allow Valent BioSciences to further study the effectiveness of this breakthrough adulticide in various field trials throughout the U.S.

To learn more about mosquito resistance worldwide and the product development history of VBC-60748, please visit www.publichealthlandscape.com.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:

Jason Clark | Global Business Manager

Public Health and Forest Health Business
Valent BioSciences LLC
630-730-4200
jason.clark@valentbiosciences.com

Download News Release

Sumitomo Chemical announces executive leadership appointments across the Valent group of companies

FOR IMMEDIATE RELEASE

SAN RAMON, Calif., and LIBERTYVILLE, Ill., April 7, 2022 – Sumitomo Chemical Company (SCC), parent company of Valent U.S.A and Valent BioSciences, today announced senior executive appointments, effective April 1.

Matt Plitt, executive vice president and chief operating officer of Valent U.S.A. since 2014, has been appointed president and CEO of Valent U.S.A., which includes subsidiaries Valent de Mexico and Valent Canada.  Plitt joined Valent in 2010 as vice president, Sales.  He has a proven track record of understanding and delivering on customer expectations in the agriculture industry, serving in a variety of leadership roles of increasing responsibility.

Plitt will report to Juan Ferreira, who has been named managing executive officer of SCC and executive vice chair of Valent U.S.A. Ferreira joined Sumitomo Chemical in 2019.  He leads and manages the business for the Latin America region.  He has served as a global advisor to SCC’s Health & Crop Sciences Sector including the Valent group of companies and now becomes the executive vice chair of the Valent U.S.A. Board of Directors.  This will enable greater collaboration and innovation across North and South America.  Ferreira will continue to report to Dr. Nobuaki Mito, Representative Director & Senior Managing Executive Officer (President of the Health & Crop Sciences Sector), Sumitomo Chemical.

Ted Melnik, executive vice president and COO of Valent BioSciences (VBC) has been named president and CEO of Valent BioSciences, which includes Pace International and Mycorrhizal Applications. He was named COO of VBC in 2013 and is leading the expansion of the global biorational business, a major focus area for Sumitomo Chemical.  Melnik will continue to report to Dr. Nobuaki Mito.

Andy Lee, president and CEO of Valent U.S.A., and Valent BioSciences has been appointed president and CEO of a newly created company that will integrate and provided corporate services across the Valent group of companies.  Lee will continue to report to Dr. Nobuaki Mito and will serve on the Board of Directors for Valent U.S.A. and VBC. Lee has served in key leadership roles in the North American agriculture industry and has led diverse teams and complex enterprise integration initiatives across the Valent group since 2011.

###

About Valent U.S.A.

Valent U.S.A. LLC, headquartered in San Ramon, Calif., develops and markets products in the United States, Mexico and Canada that advance sustainable agriculture, protect crops, enhance crop yields, improve food quality, beautify the environment, and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide, and plant growth regulator products for agricultural, seed protection and professional use.

Valent is a leader in marketing and sales of both traditional chemical products and biorational products developed by its affiliate, Valent BioSciences LLC. For more information about Valent or our full product line, please call 800-6-VALENT (682-5368) or visit valent.com.

About Valent BioSciences LLC

Headquartered in Libertyville, Ill., Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical, and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical is one of Japan’s leading chemical companies. It offers a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. For additional information, visit the company’s website at https://www.sumitomo-chem.co.jp/english/.

For more information, contact:
Steve Tatum
(925) 951-3164
steve.tatum@valent.com

Download News Release

Valent BioSciences Creates New Biostimulant Operating Unit Supporting Parent Company Sumitomo Chemical’s Goal of Carbon Neutrality by 2050

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Illinois, February 16, 2022 – To further help support the goal of its parent company, Sumitomo Chemical Co., Ltd., to achieve carbon neutral status by 2050, Valent BioSciences LLC announced today that it is establishing a new operating unit designed to expand its biostimulant line with new internally and externally developed products for both the U.S. and global markets in this important and rapidly growing crop production segment.

The new organization will be created and fully staffed over the next few months, enabling it to become functional ahead of the 2023 crop season in the U.S. market.

Sumitomo Chemical has announced a commitment to achieve carbon neutrality by 2050, aiming to reduce the amount of greenhouse gases emitted by its production activities and business activities toward zero. Another area of focus to achieve carbon neutrality is the development of products and technologies across Sumitomo Chemical that can help advance the goal of carbon neutrality for society as a whole.

The new biostimulant unit will work with partners in discovering, developing, and commercializing arbuscular mycorrhizal fungi (AMF) products.

AMF technology supports this initiative effectively because AMF form a symbiotic relationship with approximately 90% of terrestrial plant species (including crops and forest trees) that provides many benefits, including the sequestration of carbon and improved soil health. As a result of this process, mycorrhizal fungi act as a direct air capture technology, which is trademarked as EcoDacTM by Sumitomo Chemical.

“Establishment of this new operating unit will assist us in growing our AMF business and helping meet rising U.S. crop production market industry demands for carbon-smart technologies,” said Salman Mir, Valent BioSciences’ Chief Commercial Officer and Chief Operating Officer of Mycorrhizal Applications. “This will benefit not only our customers, but society as a whole as we focus on helping growers in sequestering more carbon. It will also spur rapid development of global biostimulant products, which continue to attract increased interested and acceptance from growers around the world.”

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:

John Mandel
Valent BioSciences LLC
+1-847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

U.S. EPA Approves Expanded Use of LEAP® ES Bacterial Disease Management Biological Insecticide from Valent BioSciences

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., February 1, 2022 – Valent BioSciences has announced that the U.S. EPA (Environmental Protection Agency) has approved the expanded use of LEAP® ES Bacterial Disease Management Biological Insecticide. As a result of this approval, LEAP ES is now registered for preventative use against cabbage Black Rot and Goss’s Wilt in sweet corn. It was approved previously for use on tomatoes and peppers.

LEAP ES features a distinctive mode of action and is the only alternative to copper-based products that, as part of a program, delivers two-way protection from both bacterial diseases and lepidopteran larvae that can reduce crop quality and yield.

The product triggers plant defenses to minimize effects from bacterial diseases while controlling yield-diminishing lepidopteran larvae that can increase pathogen points of entry. LEAP ES contains methyl salicylate (MeSA), a powerful plant compound that elicits a plant’s natural defense systems against pathogen infections without reducing crop yield.

“This expanded registration means that more growers will be able to utilize LEAP ES to control bacterial disease and worm problems on their crops,” said Rosa Gimenez, Valent BioSciences’ Global Business Director, Biorational Crop Protection. “LEAP ES offers a proven and effective biorational product solution that is ideal for the needs of today’s growers.”

LEAP ES is available through Valent U.S.A.’s extensive distribution network.

Click here to learn more about LEAP ES Bacterial Disease Management Biological Insecticide.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:

John Mandel
Valent BioSciences LLC
+1-847-968-4728
Email: john.mandel@valentbiosciences.com

 

Download News Release

Valent BioSciences Announces Osage Facility Environmental Initiatives

FOR IMMEDIATE RELEASE

OSAGE, Iowa, January 12, 2022 – Valent BioSciences LLC announced today that it is undertaking two major environmental initiatives at its biorational manufacturing facility in Osage, Iowa. They include a new prairie restoration project and solar field, both situated on existing Valent BioSciences land, which will provide a variety of benefits to the local community.

Prairie Restoration Project

Valent BioSciences is restoring 34 acres of highly diverse native prairie on its land in Mitchell County, Iowa, which will be accessible to the public. This project will help establish and support a diverse native habitat for birds, butterflies, insects, reptiles, and small wildlife. The prairie will also become a rest stop for monarch butterflies that migrate to and from Mexico each year.

At maturation, the prairie will sequester approximately 170 tons of carbon dioxide annually, helping mitigate the effects of greenhouse gas in the environment. Another environmental benefit is that it will need little maintenance and won’t require the application of fertilizers or pesticides.

The prairie will be available for local community and school use. A walking path will make it easy for visitors to traverse the prairie and interact with nature.

In conjunction with the project, Valent BioSciences applied for and received a grant for prairie seed from the U.S. Department of Agriculture and Iowa Natural Resources Conservation Service.

Solar Field

The 1.5-megawatt alternating current (AC) solar field will be constructed on 12 acres of Valent BioSciences land adjacent to the prairie restoration project in conjunction with its partners, OneEnergy Renewables and Heartland Power Cooperative. This field will include approximately 3,700 bifacial solar panels that produce power from both sides of the panel and also track the sun from east to west. Once the solar field is operational, the Osage facility will receive the Renewable Energy Certificates (RECs) generated by the solar field. This project ensures that renewable energy will help power the Valent BioSciences facility.

The solar field is expected to produce about 3.4 million kilowatt hours of solar-generated electricity annually, which is anticipated to provide approximately 8% of the Osage facility’s total annual electricity usage. This amount of electricity generated is enough to power approximately 425 average-sized homes annually.

“We are proud to support these environmental initiatives, which align with our focus on sustainability and enhancing the quality of life in our local communities,” said Paul Kelley, Valent BioSciences’ Vice President of Supply Chain and Manufacturing. “Much work has also been going on behind the scenes to make these initiatives a reality, and we want to thank OneEnergy Renewables, the Heartland Power Cooperative, the City of Osage, the Mitchell County Conservation Board, and Pheasants Forever for their valuable contributions and assistance.”

“OneEnergy is excited to work with Valent BioSciences and Heartland Power Cooperative on this exceptional project,” said Tobin Booth, OneEnergy’s CEO. “We look forward to working with the community and county to permit the project this winter, and then to construct the site starting in the spring.”

“We are thankful for the opportunity to partner with Valent BioSciences and OneEnergy on this project,” said Heartland Power Cooperative CEO Jon Leerar. “By working together, Heartland Power Cooperative and OneEnergy are able to provide knowledge and experience in the energy industry to help Valent BioSciences reach their sustainability goals.”

The 46-acre parcel of land that will be the home for the prairie and solar field was removed from row crop production during the fall and the 34-acre prairie site was planted on December 1 with a pollinator mix that includes high-quality annual and perennial wildflowers. Construction on the solar field is intended to start in April 2022, with an anticipated completion date in September 2022. Valent BioSciences has also planted more than 200 trees of different species around its Osage facility during the past two years.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:

John Mandel
Valent BioSciences LLC
847-968-4728
Email: john.mandel@valentbiosciences.com

About OneEnergy Renewables

OneEnergy Renewables develops and delivers community and utility-scale solar energy facilities across the United States. OneEnergy’s mission is to make clean energy the number one electricity choice for consumers and utilities. Powered by the belief that the future will run on clean energy, its team works collaboratively with landowners, communities, and utility companies to deliver breakthrough clean energy facilities. For more information, please visit: www.oneenergyrenewables.com.

Media Contact:

Carmen Murray
OneEnergy Renewables
Email: carmen@oneenergyrenewables.com

About Heartland Power Cooperative

Heartland Power Cooperative is a member-owned rural electric distribution cooperative with offices in Thompson and St. Ansgar, IA. Heartland Power serves nearly 5,300 homes, farms, businesses, and industry with over 1,900 miles of electric power lines across 12 counties in Northern Iowa and Southern Minnesota. We are committed to providing members with quality and affordable energy services that both meet and exceed their expectations. Heartland Power is a Touchstone Energy Cooperative. For more information visit our website at www.heartlandpower.com.

Media Contact:

Jessica Marzen; Marketing & Communication Representative
Heartland Power Cooperative
Email: jmarzen@heartlandpower.com

 

Download News Release

Valent BioSciences and Kansas State University Sign Collaborative Agreement for Soil Health Research Initiative with Dr. Charles W. Rice

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL., September 23, 2021Valent BioSciences LLC and Kansas State University, Manhattan, Kansas, announce a formal long-term agreement to advance critical research in the areas of soil health and carbon smart farming. Kansas State University Distinguished Professor of Soil Microbiology, Dr. Charles W. Rice, a world-renowned researcher in carbon cycling and climate change, will oversee this initiative. A portion of the project funding will provide support for a doctoral student and a postdoctoral researcher.

“This collaboration with Kansas State University marks the next important and exciting step in our commitment to soil health in agriculture,” said Dr. Warren Shafer, Vice President, Global R&D and Regulatory Affairs at Valent BioSciences. “The specific projects being conducting with the university will help us remain the thought leader in the fields of carbon and nitrogen cycling, as influenced by the soil microbiome. These projects are part of a larger initiative led by our parent company, Sumitomo Chemical Company, to mitigate climate change by reducing carbon dioxide in the atmosphere.”

The overarching goal of the collaborative program with Kansas State University is to study the complex interactions that control soil carbon stability and carbon and nitrogen dynamics. The joint research team will evaluate how MycoApply® brand soil inoculants (containing arbuscular mycorrhizal fungi) and soil conservation management practices together influence soil health. Healthy agricultural soils can reduce the impacts of climate change and offset greenhouse gases by stabilizing nitrogen and carbon.

Soil cores from the Kansas State University studies will be evaluated and analyzed at the Donald Danforth Plant Science Center in St. Louis, Missouri, using the organization’s state-of-the-art imaging technologies.Valent BioSciences maintains an ongoing collaboration with the Danforth Center to further define and shape the science of soil health. Scientists at the Danforth Center are using X-ray imaging equipment and computer learning to pioneer new techniques that shape the way we observe interactions between plant roots and beneficial soil microorganisms within the rhizosphere.

“This private/public partnership leverages global strengths for both organizations to address significant climate change research needs,” said David V. Rosowsky, Kansas State University Vice President for Research. “Dr. Rice’s unmatched expertise in soil health will be invaluable to this initiative, as will the tremendous assets our corporate partners can provide. This is a model for how the nation’s land-grant universities can address global issues.”

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Kansas State University

Founded in 1863 as the nation’s first operational land-grant university, Kansas State University is a Tier 1 research university. Called the “Silicon Valley for biodefense,” the university is among the world’s foremost global food and biosecurity institutions, providing leadership on some of the today’s greatest challenges, including food safety and security and climate change.

About Dr. Charles W. Rice

Dr. Charles W. Rice specializes in soil microbiology, carbon cycling, and climate change, and has conducted extensive research in all of these areas. He is the first recipient of the Mary L. Vanier University Professorship at Kansas State University, which honors and supports innovative faculty members who are doing exceptional work. In addition, he was named 2020 Educator of the Year by the Mid America CropLife Association. Rice was part of the Intergovernmental Panel on Climate Change that was awarded the Nobel Peace Prize in 2007. He is also the Chair, Board on Agriculture and Natural Resources, at the National Academies of Science, Engineering, and Medicine. Rice earned a doctorate in soil microbiology and an M.S. in soil science from the University of Kentucky, and a B.S. in geography, natural environmental systems from Northern Illinois University.

About the Donald Danforth Plant Science Center

Founded in 1998, the Donald Danforth Plant Science Center is a not-for-profit research institute with a mission to improve the human condition through plant science. Research, education and outreach aim to have impact at the nexus of food security and the environment, and position the St. Louis region as a world center for plant science. The Center’s work is funded through competitive grants from many sources, including the National Science Foundation, National Institutes of Health, U.S. Department of Energy, U.S. Agency for International Development, and the Bill & Melinda Gates Foundation. Follow us on Twitter at @DanforthCenter.

Media Contact:

John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Announces U.S. EPA Registration of AccedeTM Plant Growth Regulator for Effective Thinning of Stone Fruit and Apples

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., June 30, 2021 – Valent BioSciences LLC announces U.S. EPA (Environmental Protection Agency) registration of a new plant growth regulator (PGR), which will be marketed under the brand name AccedeTM, utilizing the active ingredient 1-aminocyclopropane-1-carboxylic acid (ACC).

Accede is the first PGR based on a naturally occurring compound developed specifically for thinning of stone fruit, including peaches and nectarines. It also gives apple growers an effective tool to thin apples in the late thinning window when fruit are 15-20 mm in diameter. Until now, no fruit thinner has provided reliable thinning at this stage of development. Use of Accede will reduce the need for costly hand thinning to adjust the crop load and generate higher fruit quality and grower returns.

ACC occurs naturally in plants. Once applied to the crop, the active ingredient in Accede is quickly converted to ethylene using the plant’s natural biochemical pathways. The ethylene generated after application of Accede stimulates and accelerates flower and fruit drop in apples and stone fruit.

Accede does not leave ACC residues at harvest, as it is rapidly broken down in plants. The product was classified as a biochemical by the EPA in 2015. The technology in Accede is covered by numerous patents.

“This game-changing plant growth regulator will revolutionize the way tree fruit growers manage their crop loads,” said Dr. Warren Shafer, Vice President of Global Research and Development and Regulatory Affairs at Valent BioSciences. “Its registration in the U.S. is the culmination of more than a decade of research and development collaboration between Valent BioSciences, Valent U.S.A. LLC and our parent company, Sumitomo Chemical Co., Ltd. We are proud to bring this unique, effective biorational product to market and help growers realize its tremendous benefits.”

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences and Valent U.S.A. Collaborate with Halo on Open Innovation Initiative Seeking New Technologies and Solutions

FOR IMMEDIATE RELEASE

SAN RAMON, Calif., June 23, 2021 – Valent BioSciences  and Valent U.S.A. are collaborating with Halo to launch an open innovation initiative utilizing Halo’s state-of-the-art technology platform. This platform connects enterprises with universities, researchers and start-ups around the world to effectively crowd-source innovative ideas, technologies and solutions with experts who are working on either solving the same problems or similar problems across a range of scientific endeavors that could be applied elsewhere.

Utilizing Halo, sponsors post areas of interest for research collaborations through requests for proposals (RFPs), and scientists respond with simple, standardized proposals. Organizations then review the proposals and reach out directly to learn more or provide feedback. If the parties are interested in sharing confidential information or negotiating an agreement, the conversation moves off of Halo and the process proceeds as usual with any industry collaboration.

“Halo is a marketplace and network that drives science forward by connecting scientists directly with leading companies to promote research collaborations and funding opportunities,” said Kevin Leland, CEO and founder of Halo. “We’re thrilled to partner with industry leaders Valent BioSciences and Valent U.S.A. so that researchers who share their dedication to agricultural sustainability can benefit from their expertise and resources.”

In its first venture with Halo, Valent BioSciences and Valent U.S.A. are focused on finding partners to further their research in three specific areas. These areas include soil carbon sequestration, the ecosystem services benefits of mycorrhizal fungi colonization and novel compounds that can bolster crop protection and enhancement portfolios. The three RFPs are posted on the Halo website for interested parties to learn more about the various opportunities.

In addition, Valent BioSciences and Valent U.S.A. are hosting several webinars on June 29 that will provide additional details about the companies and RFPs. Participants can register for these webinars on the Halo website.

“We are excited to collaborate with Halo in tackling some of our planet’s most urgent challenges in accordance with our commitment to the UN Sustainable Development Goals (SDGs),” said Dr. Warren Shafer, Vice President, Global R&D and Regulatory Affairs, Valent BioSciences. “With an opportunity to shape the future, we look to reach beyond our corporate boundaries to engage with like-minded collaborators and innovative technologies that can be tailored into sustainable and leading-edge solutions that will help our growers and the planet thrive. We believe that through our partnership with Halo, Valent Biosciences and Valent U.S.A. can broaden our connection to the global scientific and business communities, while communicating our commitment to people, planet and productivity.”

 About Halo

Halo is a partnering platform where companies and scientists join forces to bring new innovations to market. Through a simple, streamlined RFP process, companies can quickly review proposals with their team, learn about new technologies and cultivate relationships with the scientists behind them. For more passive scouting and brand building, companies can highlight existing research partnerships and technology interests on their innovation page. Since launching in January 2020, Ph.D. scientists and startups across 65 countries and six continents have submitted more than 1,000 proposals on Halo. To learn more, visit halo.science/sponsors.

 About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Valent U.S.A. LLC

Valent U.S.A., headquartered in San Ramon, California, develops and markets products in the United States, Canada and Mexico that advance sustainable agriculture, protect crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. Valent is a leader in marketing and sales of both traditional chemical products and biorational products developed by its affiliate, Valent BioSciences LLC. For additional information, visit the company’s website at: https://www.valent.com

About Sumitomo Chemical Co., Ltd.
Headquartered in Tokyo, Japan, Sumitomo Chemical is one of Japan’s leading chemical companies. It offers a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s consolidated sales revenue for fiscal year 2020 was JPY 2.287 trillion and the number of employees is about 34,000 as of March 31, 2020. For additional information, visit the company’s website at https://www.sumitomo-chem.co.jp/english/.

For more information, contact:

Steve Tatum
(925) 951-3164
Email: steve.tatum@valent.com

or

John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Introduces MetaLarv® XRP for Long-Lasting, Consistent Control in Catch Basin Mosquito Habitats

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., May 5, 2021 – Valent BioSciences, the global leader in biorational solutions for Public Health and Integrated Vector Management programs, has introduced MetaLarv® XRP, an innovative new formulation designed specifically for extended residual control of mosquito larvae in catch basins and storm drains.

Leveraging MetaLarv’s proven Triple Release Technology™ for residual control, the new XRP (extended release pouch) formulation is designed to provide mosquito abatement professionals more reliable and consistent control of West Nile virus vectors in catch basins by pairing the flexibility of a water soluble pouch with the residual control (90-100 days) of a briquet.

“We’ve learned from our customers and the literature that the active ingredient release profile and duration of traditional long-lasting catch basin treatment options can be challenging,” said Banugopan Kesavaraju, Global Technical Manager for Valent BioSciences’ Public Health and Forest Health Business Units. “We developed MetaLarv XRP to help mosquito abatement professionals overcome these challenges by combining the flexibility and immediacy of a pouch with the long residual of an extended release briquet.”

Catch basins and storm drains are prime mosquito breeding grounds for West Nile virus vectors and can be difficult for technicians to access with certain types of products. Water soluble pouch (WSP) formulations are malleable to fit through the narrow grates that often cover these closed habitats, and release effective active ingredient immediately. The concern is that they typically provide control for only 1-2 months. For mosquito control programs that require control over a longer duration, this means more applications per season – a significant challenge in areas with hundreds or even thousands of such drains and basins.

To get a longer residual (90-120 days), many districts opt for mosquito larvicide extended release (XR) briquets, which can be dropped through grates that have openings wide enough to receive them. However, the physics of this “brick plunge” can drive briquets downward to become embedded in sludge or other debris. Such lodging reduces the amount of XR briquet surface area that comes in contact with the water column, meaning slower and diminished release of active ingredient. Water temperature also plays a role in the release profile of briquets, which lags in colder temperatures early in the season. These drawbacks often translate into inconsistent results.

MetaLarv was first introduced in 2012 as a highly functional spherical pellet (S-PT) formulation of the insect growth regulator (S)-methoprene, which disrupts insect growth and prevents the emergence of adult mosquitoes that are capable of transmitting harmful diseases such as West Nile virus, malaria, dengue fever, and encephalitis. MetaLarv S-PT provided mosquito control districts with significant operational advantages in the control of floodwater mosquitoes. Like its successor, MetaLarv S-PT combined the best features from two different formulation types; it provided the low-rate application flexibility of a granule combined with the residual control of dynamic floodwater habitats of a pellet formulation.

MetaLarv XRP now delivers Valent BioSciences’ proprietary Triple Release Technology benefits into the challenging environments of storm drains and catch basins.

When applied, MetaLarv XRP floats briefly on the water’s surface where it quickly dissolves to deposit the full volume of its Triple Release “micro briquets” into the mosquito habitat. The first release occurs immediately with a flash of active ingredient to control initial mosquito broods and is not dependent on water temperature. The second release occurs over time as a further portion of the micro briquets breaks down in standing water, allowing for control of multiple mosquito broods during a flood. The third release allows for product to withstand dry-down/reflood situations in catch basins, ensuring MetaLarv XRP is ready for the next flooding cycle. This “trifecta” approach ensures multiple point source coverage for consistent control over an extended period of time.

“We work in an industry where resources are limited and the stakes for success or failure are high,” said Kesavaraju. “When our customers make an application, they need to be able to walk away with the confidence that the resources they’ve expended are going to provide the level of control they expect. MetaLarv XRP is another example of our ongoing commitment to provide specialized solutions –based on specific mosquito larval habitats – that help public health professionals reduce the risk of vector-borne disease.”

MetaLarv XRP joins MetaLarv S-PT and the Valent BioSciences biorational mosquito larvicides, VectoBac®, VectoPrime®, VectoMax®, VectoLex®, and Bactimos®, to provide the public health industry’s most comprehensive range of target-specific, biorational larvicides for mosquito abatement professionals and health care officials around the globe.

For more information, visit www.valentbiosciences.com/publichealth or contact a Valent BioSciences technical sales representative.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release